The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females

Study identifier:H8O-EW-GWBC

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

The Effect of Exenatide on Single and Multiple Doses Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

Medical condition

Type 2 Diabetes Mellitus

Phase

Phase 1

Healthy volunteers

Yes

Study drug

ethinyl estradiol and levonorgestrel; exenatide

Sex

Female

Actual Enrollment

38

Study type

Interventional

Age

18 Years - 45 Years

Date

Study Start Date: 01 Nov 2005
Primary Completion Date: 01 Aug 2006
Study Completion Date: 01 Aug 2006

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics/dynamics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Aug 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

Eli Lilly and Company

Inclusion and exclusion criteria